Puerto Rico has a proposal on the table to, in effect, use the fallout from violent crime to boost its country's standard of living, and to, in turn, reduce crime. Lemons, meet lemonade. But is this smart or simply macabre?

Some researchers studying autism spectrum disorder seek to understand the relationship between perception and behavior in the brain. This is partly the impetus behind a recent study, which sought to learn how the world is interpreted by an ASD sufferer.

The U.S. Preventive Services Task Force recently updated its recommendations for screening for abnormal blood glucose, to include 40-to-70 year olds who are overweight or obese. But the main message is that while screenings are helpful, making better health decisions is the best overall approach.

A recent JAMA paper examines whether there are more side effects when prescription drugs are used off-label, as compared to what they were approved for. Not only does this make no sense, but the authors state there's no difference. This is like studying whether obese people weigh more than non-obese people.

The makers of DecisionDx, a new test for melanoma that's commercially available, say the potential exists for patients to receive life-saving, preventative therapies. As promising as this sounds, the data is based on a small sample size, so considerable caution is advised.

It's a popular product found in many sugar-free foods in your kitchen, but if your furry friend gets a hold of it, it could be deadly.

The cardio-protective effects of HDL, or "good" cholesterol, may become diminished as women transition through menopause. There is a possibility that it's proatherogenic, meaning it has a tendency to form plaques.

4-MEI is the reason not to avoid a Starbucks latte - 400 calories is.

Candy companies are for more sugar regulation while Ben & Jerry's is against it. What's going on?

Prostate cancer is the second leading cause of death in men worldwide. A new study, in the journal Science Translational Times, discusses the enhanced benefits of chemical castration prior to initiating radiotherapy for patients with intermediate- and high-risk prostate cancer.